Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-04-28

FDA Approved: RISPERDAL — Supplemental Application (Janssen Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Risperdal (risperidone) from Janssen Pharmaceuticals, Inc. The approval updates the drug's labeling, reflecting an a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Risperdal (risperidone)

Snippet

SUPPL AP for RISPERDAL (RISPERIDONE)